These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 33530243)

  • 1. Complementary and alternative therapies for non-alcoholic fatty liver disease: A Bayesian network meta-analysis protocol.
    Zhang T; Han D; Zhang T; Jing C; Sun J
    Medicine (Baltimore); 2021 Jan; 100(4):e24432. PubMed ID: 33530243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary and alternative therapies for precancerous lesions of gastric cancer: A protocol for a Bayesian network meta analysis.
    Zhang T; Zhang T; Li C; Zhai X; Huo Q
    Medicine (Baltimore); 2021 Jan; 100(2):e24249. PubMed ID: 33466209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary and alternative therapies for tension-type headache: A protocol for systematic review and network meta-analysis.
    Zhai X; Zhang S; Li C; Liu F; Huo Q
    Medicine (Baltimore); 2021 Apr; 100(16):e25544. PubMed ID: 33879702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacy and safety of complementary and alternative therapies for primary trigeminal neuralgia: A protocol for a Bayesian network meta analysis.
    Zhang T; Zhang T; Li C; Zhai X; Huo Q
    Medicine (Baltimore); 2021 Jan; 100(2):e24212. PubMed ID: 33466199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of efficacy and safety of complementary and alternative therapies for coronary heart disease complicated with anxiety or depression disorder: A protocol for Bayesian network meta-analysis.
    Han X; Liu X; Zhong F; Wang Y; Guan H; Zhang Q
    Medicine (Baltimore); 2021 Mar; 100(12):e25084. PubMed ID: 33761669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy and safety of complementary and alternative therapies for scapulohumeral periarthritis: A protocol for Bayesian network meta-analysis.
    Gao M; Cong H; Li C; Qin X; An H; Jiang Z
    Medicine (Baltimore); 2021 May; 100(18):e25769. PubMed ID: 33950966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the efficacy and safety of complementary and alternative therapies for ulcerative colitis: A protocol for systematic review and meta-analysis.
    Lu M; Zhang T; Lu Z; Wang W; Chen T; Cao Z
    Medicine (Baltimore); 2020 Jul; 99(28):e21219. PubMed ID: 32664174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of efficacy and safety of complementary and alternative therapies for Parkinson's disease: A Bayesian network meta-analysis protocol.
    Li C; An H; Wang J; Jiang Z; Zhang T; Huo Q
    Medicine (Baltimore); 2020 Sep; 99(38):e22265. PubMed ID: 32957377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of chemotherapy combined with different doses of IL-2 maintenance therapies for acute myeloid leukemia: A protocol for a Bayesian network meta-analysis.
    Yin X; Ding Y; Yu L; Guo C; Cui Y; Zhai X; Wang Y; Ding S; Shen M; Li Z; Xu R
    Medicine (Baltimore); 2021 Jun; 100(23):e26098. PubMed ID: 34114994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy and safety of complementary and alternative therapies for essential hypertension with anxiety or depression disorder.
    Han X; Liu X; Zhong F; Wang Y; Zhang Q
    PLoS One; 2021; 16(7):e0254699. PubMed ID: 34270618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and safety of traditional Chinese patent medicine for NAFLD in childhood or adolescence: A protocol for a Bayesian network meta analysis.
    Sun Y; Tan Z; Jiang Z; Li M; Wang W; Huang Y; Sun J
    Medicine (Baltimore); 2021 Jan; 100(3):e24277. PubMed ID: 33546051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the efficacy and safety of complementary and alternative therapies for premature ovarian insufficiency: A protocol for network meta-analysis.
    Zhang L; Li H; Zhang J; Kong X; Wu Z; Dong S; Qin X
    Medicine (Baltimore); 2020 Jul; 99(31):e21538. PubMed ID: 32756205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and safety of complementary and alternative therapies for tubal obstructive infertility: A protocol for network meta-analysis.
    Dong SQ; Zhao XL; Sun Y; Zhang JW
    Medicine (Baltimore); 2021 Feb; 100(7):e24810. PubMed ID: 33607845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary and alternative therapies for stable angina pectoris of coronary heart disease: A protocol for systematic review and network meta-analysis.
    Wang G; Li F; Hou X
    Medicine (Baltimore); 2022 Feb; 101(7):e28850. PubMed ID: 35363183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of efficacy and safety of complementary and alternative therapies for children with asthma: A protocol for systematic review and meta analysis.
    Zhou P; Xi L; He H; Zhang B; Li Y
    Medicine (Baltimore); 2021 Mar; 100(11):e24946. PubMed ID: 33725965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional Chinese medicine for mild-to-moderate ulcerative colitis: Protocol for a network meta-analysis of randomized controlled trials.
    Shen Z; Zhou Q; Ni Y; He W; Shen H; Zhu L
    Medicine (Baltimore); 2019 Aug; 98(33):e16881. PubMed ID: 31415431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the efficacy and safety of complementary and alternative therapies for gastroesophageal reflux disease: A protocol for network meta-analysis.
    Zhang S; Jiang Q; Mu X; Wang Z; Liu S; Yang Z; Xu M; Ren X; Wang Y
    Medicine (Baltimore); 2020 Jul; 99(30):e21318. PubMed ID: 32791724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acupuncture combined with Chinese herbal medicine on non-alcoholic fatty liver disease: A protocol for systematic review and meta-analysis.
    Ma Y; Sun K; Cao J; Qin X; Shi J; Li H; Zhang J; Zhang T
    Medicine (Baltimore); 2021 Dec; 100(51):e28083. PubMed ID: 34941049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xiaoyao Powder in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Liu N; Yang J; Ma W; Li C; An L; Zhang X; Zou Q
    J Ethnopharmacol; 2022 Apr; 288():114999. PubMed ID: 35051605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of omega-3 fatty acids on liver-related outcomes in patients with nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis.
    Shi XY; Fan SM; Shi GM; Yao J; Gao Y; Xia YG; Chen Q
    Medicine (Baltimore); 2020 Jun; 99(24):e20624. PubMed ID: 32541499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.